Cargando…

HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation

Human cytomegalovirus (HCMV) is under constant selective pressure from the immune system in vivo. Study of HCMV genes that have been lost in the absence of, or genetically altered by, such selection can focus research toward findings of in vivo significance. We have been particularly interested in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Mihil, Vlahava, Virginia-Maria, Forbes, Simone K., Fielding, Ceri A., Stanton, Richard J., Wang, Eddie C. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174198/ https://www.ncbi.nlm.nih.gov/pubmed/30327650 http://dx.doi.org/10.3389/fimmu.2018.02214

Ejemplares similares

Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells
por: Gao, Fei, et al.
Publicado: (2022)

Impact of HCMV Infection on NK Cell Development and Function after HSCT
por: Della Chiesa, Mariella, et al.
Publicado: (2013)

Downregulation of HLA-I by the molluscum contagiosum virus mc080 impacts NK-cell recognition and promotes CD8(+) T-cell evasion
por: Elasifer, Hana, et al.
Publicado: (2020)

Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
por: Berg, Christian, et al.
Publicado: (2023)

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
por: Lazar, Katrin, et al.
Publicado: (2021)

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
por: Fielding, Ceri Alan, et al.
Publicado: (2022)

ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways
por: Rubina, Anzelika, et al.
Publicado: (2023)

Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023)

Intragenic variations in the HCMV RL11-family
por: Sekulin, K., et al.
Publicado: (2006)

Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
por: Rousselière, Amélie, et al.
Publicado: (2023)

NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
por: Wu, Zeguang, et al.
Publicado: (2019)

Concerns over functional experiments, interpretation, and required controls
por: Wang, Eddie C.Y., et al.
Publicado: (2022)

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
por: Koch, Christine, et al.
Publicado: (2017)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Chronic Ly49H Receptor Engagement in vivo Decreases NK Cell Response to Stimulation Through ITAM-Dependent and Independent Pathways Both in vitro and in vivo
por: Key, Phillip N., et al.
Publicado: (2019)

Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT
por: Zaghi, Elisa, et al.
Publicado: (2021)

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
por: Falk, Jessica Julia, et al.
Publicado: (2018)

Broad and Efficient Activation of Memory CD4(+) T Cells by Novel HAdV- and HCMV-Derived Peptide Pools
por: Höttler, Alexander, et al.
Publicado: (2021)

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis
por: Lauruschkat, Chris David, et al.
Publicado: (2023)

Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C(+)CD57(+)NK and δ2(-)γδT cell subsets
por: Rousselière, Amélie, et al.
Publicado: (2022)

Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo
por: Lanuza, Pilar M., et al.
Publicado: (2022)

Enhancement of cytokine‐driven NK cell IFN‐γ production after vaccination of HCMV infected Africans
por: Darboe, Alansana, et al.
Publicado: (2017)

The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity
por: Jenks, Jennifer A., et al.
Publicado: (2019)

HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites
por: Davies, Emma L., et al.
Publicado: (2022)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

IFN type III: in vivo NK cell response
por: Souza-Fonseca-Guimaraes, Fernando, et al.
Publicado: (2015)

Sequencing of the Viral UL111a Gene Directly from Clinical Specimens Reveals Variants of HCMV-Encoded IL-10 That Are Associated with Altered Immune Responses to HCMV
por: Waters, Shelley, et al.
Publicado: (2022)

Modulation of NK cell activation by exogenous calcium from alginate dressings in vitro
por: Adib, Yara, et al.
Publicado: (2023)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
por: Ruppel, Katharina Eva, et al.
Publicado: (2022)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Discordance Between the Predicted Versus the Actually Recognized CD8+ T Cell Epitopes of HCMV pp65 Antigen and Aleatory Epitope Dominance
por: Lehmann, Alexander A., et al.
Publicado: (2021)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

NK Cell Exhaustion
por: Bi, Jiacheng, et al.
Publicado: (2017)

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells
por: Seidel, Einat, et al.
Publicado: (2015)

HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3
por: Ising, Ricarda, et al.
Publicado: (2019)

ADAP Promotes Degranulation and Migration of NK Cells Primed During in vivo Listeria monocytogenes Infection in Mice
por: Böning, Martha A. L., et al.
Publicado: (2020)

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021)

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
por: Silvestre, Renata Nacasaki, et al.
Publicado: (2023)

Insight for Immunotherapy of HCMV Infection
por: Long, Xinmiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or99j0tvovlc7kuvjft7nf2h7q